News - Boston Scientific EMEA

EMEA Newsroom

Welcome to our newsroom for the Europe, Middle East & Africa region.

Featured Stories

Sep 19, 2023

Pain Awareness Month - Chronic Pain Survey Reveals Challenges Faced by Patients

Sep 12, 2023

Caroline Bravo appointed VP of Rhythm Management in EMEA region

Aug 22, 2023

CIRSE Provides Updated Guidance on The Use of Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease 

View all

Sep 5, 2023

New Survey Reveals Challenges Faced by Chronic Pain Patients in Seeking Treatment

HEMEL HEMPSTEAD, United Kingdom – 5 Sept. 2023 – Boston Scientific (NYSE: BSX) today revealed survey results of 2,000 people living with chronic pain in the United Kingdom (UK) that unveiled...

May 18, 2023

Boston Scientific Announces €80M Investment and 400+ Jobs at Clonmel Site

Taoiseach Leo Varadkar joins company’s 25-year anniversary celebrations in Clonmel CLONMEL, IRELAND (19 May 2023) - Boston Scientific Corporation (NYSE: BSX) will today announce an €80 million...

All Releases

Nov 8, 2022

Boston Scientific amplía su oferta de diagnóstico en Europa con el lanzamiento del sistema de monitor cardíaco insertable LUX-Dx™

MADRID, 8 de noviembre de 2022 - Boston Scientific ha anunciado hoy, a la comunidad médico-científica especializada, el lanzamiento en Europa del Sistema de Monitor Cardíaco Insertable (MCI)...

Sep 2, 2021

Boston Scientific lanza FAST: una nueva terapia para la estimulación de la médula espinal

MARLBOROUGH, Mass., 2 de septiembre, 2021- Boston Scientific (NYSE: BSX) anunció hoy el lanzamiento en Europa de la terapia FAST para sus sistemas de estimulación de la médula espinal (SCS)...

All Releases

Sep 5, 2023

Umfrage zu Chronische Schmerzen in Deutschland Enthüllt, dass Diese Unterdiagnostiziert Sind, und Welche Gründe vom Arztbesuch Abhalten

Düsseldorf – 5. September 2023 – Boston Scientific veröffentlichte heute Ergebnisse einer repräsentativen Befragung von 1.000 Menschen mit chronischen Schmerzen, laut denen dieses Leiden in...

Nov 8, 2022

Boston Scientific erweitert Diagnostikangebot in Europa mit der Einführung des implantierbaren Herzmonitorsystems LUX-Dx

Düsseldorf, 8. November 2022 – Die Boston Scientific Corporation (NYSE: BSX) gab heute die Markteinführung des LUX-Dx Insertable Cardiac Monitor (ICM) Systems in Europa bekannt. Das...

All releases

Nov 8, 2022

Boston Scientific amplia l’attività diagnostica in Europa con il nuovo sistema di monitoraggio cardiaco inseribile LUX-Dx™

Milano, 8 novembre 2022 - Boston Scientific Corporation (NYSE: BSX) ha annunciato oggi l’introduzione in Europa del nuovo monitor cardiaco inseribile LUX-Dx™ (ICM), un dispositivo diagnostico...

Jun 21, 2022

Ripristinare funzioni vitali e qualità di vita dopo l’asportazione di un tumore alla prostata: le opzioni terapeutiche risolutive e sostenibili per l’incontinenza urinaria maschile

Ripristinare funzioni vitali e qualità di vita dopo l’asportazione di un tumore alla prostata: le opzioni terapeutiche risolutive e sostenibili per l’incontinenza urinaria maschile Milano, 21...

All Releases

Key Dates